{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:16:25Z","timestamp":1787008585842,"version":"build-2736575974"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fatal outcomes in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS) are reported to be associated with cytomegalovirus (CMV) reactivation. However, CMV reactivation is observed not only in DIHS\/DRESS but also in other diseases when high doses of corticosteroids are administered. Currently, it is difficult to distinguish whether CMV reactivation in DIHS\/DRESS is caused by steroid-induced immunosuppression or the pathology of DIHS\/DRESS. In this study, we describe the characteristic of CMV reactivation in patients with DIHS\/DRESS (n = 22) by comparing the frequency of reactivation and its complications with those that occur in people with pemphigus vulgaris (PV) (n = 21) treated with high doses of corticosteroids. The frequency of CMV reactivation showed no difference between the DIHS\/DRESS and PV groups. On the other hand, the frequency of CMV complications was higher in the DIHS than the PV group. Our data show the importance of monitoring for CMV complications, although CMV reactivation is not a unique consequence of DIHS\/DRESS compared with other diseases treated with a high dose of corticosteroids.<\/jats:p>","DOI":"10.1093\/ced\/llae372","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:31:46Z","timestamp":1725237106000},"page":"399-403","source":"Crossref","is-referenced-by-count":4,"title":["Cytomegalovirus complications in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: importance of routine monitoring and early therapeutic intervention"],"prefix":"10.1093","volume":"50","author":[{"given":"Shingo","family":"Takei","sequence":"first","affiliation":[{"name":"Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-531X","authenticated-orcid":false,"given":"Ryota","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Hama","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riichiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"2025012715565724600_llae372-B1","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2025012715565724600_llae372-B2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"2025012715565724600_llae372-B3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"2025012715565724600_llae372-B4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"key":"2025012715565724600_llae372-B5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/s10165-011-0519-3","article-title":"Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases","volume":"22","author":"Hanaoka","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2025012715565724600_llae372-B6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/1346-8138.12486","article-title":"Japanese guidelines for the management of pemphigus","volume":"41","author":"Committee for Guidelines for the Management of Pemphigus Disease","year":"2014","journal-title":"J Dermatol"},{"key":"2025012715565724600_llae372-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"2025012715565724600_llae372-B8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.alit.2021.12.002","article-title":"Drug allergy and non-HIV immune reconstitution inflammatory syndrome","volume":"71","author":"Sueki","year":"2022","journal-title":"Allergol Int"},{"key":"2025012715565724600_llae372-B9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.13079","article-title":"Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?","volume":"171","author":"Almudimeegh","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae372\/60416427\/llae372.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/2\/399\/60416427\/llae372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/2\/399\/60416427\/llae372.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:57:33Z","timestamp":1737975453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/2\/399\/7747225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":9,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,9,2]]},"published-print":{"date-parts":[[2025,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae372","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,9,2]]}}}